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Background: The transient receptor potential cation channel subfamily V member 1 (TRPV1)
channel has been proved to be a molecular integrator of inﬂammatory pain sensation.
2-Aminoethoxydiphenyl borate (2-APB) and its analogs have been noticed as attractive
candidates for the development of a selective TRPV1 agonist and/or antagonist. However,
selectivity and effectiveness, species dependence, and the binding site(s) of 2-APB on TRPV1
channel protein remain controversial.
Methods: The present study aimed to characterize acting sites of 2-APB on heterologously
expressed rat TRPV1 (rTRPV1) channels in HEK 293 cells. Rat TRPV1 currents were recorded
by cell-free, excised patch clamp techniques.
Results: In inside-out and outside-out patch modes, 2-APB applied either side of the mem-
brane dose-dependently activated rTRPV1 channels. 2-APB dose-dependently potentiated
rTRPV1 currents, that activated by capsaicin, protons, or noxious heat. 2-APB potentiated
the capsaicin-activated rTRPV1 current from both side of the patch membrane. A structural
analogue of 2-APB, diphenylboronic anhydride, showed the same potentiation effect on the
capsaicin-activated rTRPV1 current.Conclusion: It is suggested that 2-APB directly opens rTRPV1 channels from both sides of the
membrane and potentiates the opening of channels by inﬂammatory stimuli.
© 2013 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
tons, endogenous lipid products, and many inﬂammatory1. Introduction
Capsaicin, a pungent ingredient of chili peppers, excites
nociceptive neurons by stimulating capsaicin receptors on
the nerve endings.1,2 Capsaicin receptor was cloned and
named as vanilloid receptor 1 or transient receptor potential
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cation channel subfamily V member 1 (TRPV1).3 In addition
to vanilloid compounds such as capsaicin, TRPV1 channels
are activated by noxious heat (> 43 ◦C), extracellular pro-edical Research Institute, Sungkyunkwan University School of
mediators.4 Interestingly, most of them are structurally unre-
lated but they all can cause pain. High expression of TRPV1
channels in dorsal root ganglionic neurons and trigeminal
vier. This is an open access article under the CC BY-NC-ND license
Kg
a
p
s
t
s
m
i
a
a
T
o
t
a
d
d
c
t
a
p
r
a
i
a
i
p
h
a
i
h
b
s
t
t
C
i
a
C
s
a
s
t
n
t
a
a
h
v
c
n
2
o
p
m
m
m.N. Mamatova and T.M. Kang/2-APB activation of rTRPV1
anglionic neurons has been demonstrated, and the channels
re now believed to be a molecular integrator of inﬂammatory
ain sensation. The essential roles of TRPV1 for pain sen-
ation have been strongly supported by mice lacking TRPV1
hat were impaired in the detection of painful inﬂammatory
timuli, painful vanilloids, and heat.5
Because TRPV1 is a good target of analgesics for inﬂam-
atory pain, many pharmaceutical companies have tried to
dentify novel and potent TRPV1 modulators. TRPV1 targeting
nalgesics are classiﬁed into two groups: TRPV1 antagonists
nd TRPV1 agonists. Although small molecular synthetic
RPV1 antagonists with improved toxicity are the major focus
f development, local treatment of TRPV1 agonists has been
ried in clinical practice. The strongTRPV1activators capsaicin
nd resiniferatoxin initially excite TRPV1 and then pro-
uce a strong desensitization of the channels or irreversibly
estroy capsaicin-sensitive sensory neurons. For this reason,
apsaicin-based TRPV1 agonists can be used when they are
opically applied by injection or patches. Successful TRPV1-
gonist-based therapy has been reported for osteoarthritis,
ostherpetic neuropathy, painful HIV-associated sensory neu-
opathy, cluster headache, migraine, urinary incontinence,
nd overactive bladder.6 Disadvantages of TRPV1 agonists
nclude a burning sensation and the need for multiple
pplications to get sufﬁcient therapeutic effects. Therefore,
dentifying and developing new TRPV1 agonists with reduced
ungency compared with capsaicin-based agonists and a
igher chemical stability have been a matter of great interest.
2-Aminoethoxydiphenyl borate (2-APB) has been described
s an inhibitor of inositol 1,4,5-trisphosphate receptor (IP3-R)-
nduced Ca2+ release from intracellular stores.7 Later studies,
owever, have revealed that 2-APB is not IP3-R speciﬁc,
ut has many targets. For example, 2-APB inhibits a native
tore-operated calcium entry (SOCE) channels8–10 and many
ransient receptor potential cation (TRPC) and transient recep-
or potential melastatin channels,11,12 endoplasmic reticulum
a2+-ATPases13 and volume-regulated anion channels,14 but
t activates phospholipase C.15 This complexity renders 2-APB
s a poor tool for the separation of IP3-R and SOCEs from other
a2+ entry pathways.
2-APBwas found to be a commonactivator of three thermo-
ensitive TRPV channels: TRPV1, TRPV2, and TRPV3.16,17 With
whole-cell patch clamp recording, it was shown that 2-APB
trongly activated mouse TRPV1 and stimulated the response
o capsaicin, heat, and acid.16,17 In addition, 2-APB sensitized
ative nociceptive neurons to heat in a mouse model.18 For
his reason, it is suggested that 2-APB analogues could be
ttractive candidates for the development of a selective TRPV1
gonist or antagonist. However, it has been noticed that 2-APB
as no effect on TRPV2 and shows a very weak effect on acti-
ating TRPV1 expressed in human embryonic kidney (HEK)
ells.19 This discrepancy remains to be explained.
Therefore, we aimed to establish whether the heteroge-
eously expressed TRPV1 channels are directly activated by
-APB and to prove the potentiation of 2-APB on the effects
f capsaicin, heat, and protons on the channels. To this pur-
ose, we recorded rat TRPV1 (rTRPV1) channels using excised
embrane patches, because the previously reported were
ainly achieved by whole-cell patch clamp recordings and
ouse TRPV1.16,19 Recording of TRPV1 current by whole-cell113
patch clamp cannot exclude the cytoplasmic components
and signaling molecules that inﬂuence overall activity of
the channels. Many cytoplasmic molecules including protein
kinase C and calmodulin kinase modulate TRPV1 activity.20,21
Assuming that these signaling molecules are relatively well
conserved in whole-cell patch recordings, the demonstration
of TRPV1 activation by 2-APB from a cell-free patches can rule
out their contribution and can distinguish from an indirect
activation mechanism.
2. Methods
2.1. Cell culture and expression of rTRPV1
HEK 293 cells were cultured at 37 ◦C, 5% CO2, in Dulbecco’s
minimal essential medium (DMEM, Gibco, Grand Island, NY,
USA) containing 4.5mg/mL glucose, 10%heat-inactivated fetal
bovine serum, 100 units/mL penicillin, 100g/mL strepto-
mycin. Rat TRPV1 cDNA was kindly provided Dr Uhtaek Oh
(Seoul National University, Korea). The cells were passaged
three times/week. Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA, USA) was used for the transfection of rTRPV1
cDNA. 35-mm dishes of HEK 293 cells at approximately 80%
conﬂuence were prepared for transfection. A 4-L aliquot of
Lipofectamine was added into 250L of Opti-MEM (Gibco)
and incubated for 5minutes at room temperature and 5g
of rTRPV1 cDNA labeled with a PIRES-EGFP ﬂuorescent tag
in 250L of Opti-MEM were added. Lipofectamine and cDNA
solution were mixed and incubated at room temperature for
20minutes. The mixture was dropped on to HEK 293 cells and
mixed gently. Cells were maintained in a humidiﬁed CO2 incu-
bator at 37 ◦C for 24–48hours.
2.2. Patch clamp
HEK cells that ﬂuoresced green underlight of wavelength
588nm were considered to be transfected with rTRPV1 and
were selected for recording. Patch clamp recordings were per-
formedat roomtemperature (23–26 ◦C)with the inside-out and
outside-out conﬁgurations. Conventional whole-cell record-
ings were performed to verify the responses in outside-out
conﬁguration. Signals were ampliﬁed with an Axopatch 1D
patch clamp ampliﬁer and controlled with pClamp software
7.0 (Axon Instruments). Signals were ﬁltered at 1kHz and
recorded at 5kHz. For the inside-out patch clamp, pipettes
were pulled from micropipette glass (World Precision Instru-
ments Inc, Sarasota, FL, USA) to 1.5–2M  tip resistance
and ﬁlled with an extracellular (pipette) solution containing
140mM NaCl and 10mM Hepes (pH 7.3 with N-methyl-D-
glucamin). The cytoplasmic (bath) solution contained 140mM
NaCl, 10mM Hepes, and 2mM EGTA (pH 7.2 with N-methyl-
D-glucamin). The current was recorded at a holding potential
of –60mV. For outside-out patch clamp, the same cytoplas-
mic (pipette) and extracellular (bath) solutions, as used in
the inside-out patches, were used. Whole-cell currents were
2+recorded in a nominal Ca free extracellular (bath) solution
contained 145mM NaCl, 5mM KCl, 1mM MgCl2, and 10mM
glucose(pH 7.4). Outside-out and whole-cell currents were
recorded at a holding potential of –30mV.
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Fig. 1 – Activation of rat transient receptor potential cation channel subfamily V member 1 (TRPV1) channels by capsaicin. In
the inside-out patch conﬁguration, rat TRPV1 channels expressed in human epithelial kidney cells were dose-dependently
activated by capsaicin. (A) The capsaicin-induced current was inhibited by TRPV1 antagonist capsazepine (10M). (B) The
concentration of capsaicin was raised from 1M to 50M to construct the dose-response curves. (C) Dose-response curve
was plotted and the calculated half maximal effective concentration of capsaicin was 21.2±5.1M (n=8). The currents were
measured at a holding potential of –60mV at room temperature (∼24 ◦C).2.3. Chemicals and reagents
All chemicals used were purchased from Sigma–Aldrich (St
Louis, MO, USA). Stock solutions of 2-APB, diphenylborinic
anhydride (DPBA), capsaicin, and capsazepine were prepared
in dimethyl sulfoxide. Drugs were diluted in the appropriate
solutions to the desired ﬁnal concentrations prior to use.
2.4. Statistics
Data are presented as mean± standard error of the mean with
n of sample number. Statistical comparison was tested using
unpaired t test and signiﬁcance was set at p<0.05.
3. Results
3.1. Activation of rTRPV1 channels by 2-APB
To prove the functional expression of rTRPV1 channels in
HEK 293 cells, we ﬁrst recorded the capsaicin-activated cur-
rent with the inside-out patch conﬁguration. To prevent a
rapid desensitization of the current, we perfused the patch
membrane with a Ca2+-free cytoplasmic (bath) solution con-
taining 1mM EGTA and 140mM Na+. At a holding potentialof –60mV, capsaicin dose-dependently activated an inward
rTRPV1 current with no signiﬁcant desensitization, indicating
that the expressed channels are functional and are properly
detected from excised patch membranes (Fig. 1). Capsaicin-
activated rTRPV1 current was strongly inhibited by a TRPV1
antagonist capsazepine (10M; Fig. 1A). Half maximal con-
centration of capsaicin was 21.2±5M (n=8; Fig. 1B,C). In
excised patches, the amplitudes of the capsaicin-activated
currents were so variable that it was not possible to compare
the current obtained from a different patch. Initially, we tried
to measure density of the currents by normalizing the current
with a measured membrane capacitance. However, the nor-
malized datawere also very variable, sowe concluded that this
was probably due to a different expression level of the chan-
nels. The patch membranes were easily broken at capsaicin
concentrations>50M, so we did not use capsaicin at > 10M.
We investigated whether 2-APB activates rTRPV1 chan-
nels in excised patch membranes. In the inside-out patch
mode, cytoplasmic application of 2-APB activated an inward
rTRPV1 current at a holding potential of –60mV (Fig. 2Ai).
Capsazepine (10M) strongly inhibited the 2-APB-activated
currents suggesting that 2-APB activates rTRPV1 channels.
2-APB dose-dependently activated the current and the esti-
mated half maximal effective concentration value for 2-APB
was 277.6±64.5Mat a holding potential of –60mV (n=6, data
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Fig. 2 – Activation of rat transient receptor potential cation channel subfamily V member 1 (rTRPV1) channels by
2-aminoethoxydiphenyl borate (2-APB) in excised patches. (A) To activate rTRPV1 channels from the cytoplasmic side of the
membrane, the inside-out and outside-out patches were achieved. (i) In inside-out mode, the application of an increasing
concentration of 2-APB, from the cytoplasmic side, activated the current, which is inhibited by capsazepine (CZP, 10M). (ii)
In the outside-out patch mode, inclusion of 1mM 2-APB into the recording pipette weakly activated rTRPV1 current. In the
same patch, application of 1mM or 5mM 2-APB from the extracellular face activateda CZP-sensitive current. (iii) In the
outside-out patches, inclusion of 5mM 2-APB into the recording pipette activated the CZP-sensitive current, and the
addition of 2-APB (0.1–0.5mM) from the extracellular face further enhanced the current. (B) 2-APB activation of the channels
from the extracellular face of the membrane. (i) In the outside-out patches, extracellular 2-APB (0.5–1mM) activated rTRPV1.
Capsaicin activated and capsazepine inhibited the current, respectively. (ii) In the inside-out mode, intrapipette 2-APB
(5mM) weakly activated the current and the additional 2-APB from the cytosolic face enhanced it. Outside-out patches were
recorded at –30mV. Each panel illustrates a representative trace from 5 or 6 recordings.
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cot shown). In outside-out patches mode, inclusion of 1mM
-APB into the recording pipette weakly activated rTRPV1
urrent (Fig. 2Ai). The same results were obtained from whole-
ell recordings. This was somewhat unexpected, because the
ame concentration of 2-APB strongly activated the current
hen applied from the cytoplasmic side of the inside-out
atches (Fig. 2Ai). We therefore thought that if interference
y unknown factors reduces available 2-APB, it could be over-
ome by raising the concentration of the compound in the
ipette. To test this possibility, we raised the intrapipette 2-
PB up to 5mMand the outside-out patcheswere achieved. As
hown in Fig. 2Aiii, 5mM2-APB slowly activated the capsaicin-
ensitive current after achieving the outside-out patches. In
his condition, application of 100–500M 2-APB into the extra-
ellular space, which is much lower than intrapipette 2-APB,slightly activated the current. This indicates that, 2-APB has
binding sites not only on the cytoplasmic but also extracellular
side.
To determine whether the extracellular 2-APB activates
rTRPV1, we recorded the current in outside-out patch mode.
As shown in Fig. 2Bi, 0.5–1mM 2-APB applied into the extra-
cellular side of the outside-out patch membrane activated the
capsaicin-sensitive current. In Fig. 2Bii, we included 5mM 2-
APB in the inside-out pipette solution. When the inside-out
patch membranes were excised from the cells, a detectable
current could be recorded. In the presence of 5mM of extracel-
lular 2-APB, addition of 2-APB (0.1–5mM) into the cytoplasmic
solution strongly activated the current (Fig. 2Bii). Therefore,
the results conﬁrm that 2-APB’s binding sites are located on
both sides of the membrane.
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Fig. 3 – Potentiation of the capsaicin-activated rat transient receptor potential cation channel subfamily V member 1
(rTRPV1) current by the cytoplasmic 2-aminoethoxydiphenyl borate (2-APB). (A) Representative current traces showing the
capsaicin-activated current. To normalize the current, 1mM 2-APB was added at the end of the recording with 10M
capsaicin (n=11). (B–D) Potentiation of the capsaicin-activated currents by the cytoplasmic 2-APB was shown at a
concentration of 0.1mM (n=9), 0.5mM (n=5), and 1mM 2-APB (n=9). (E) Summarized data are plotted. Detail values are
described in text.
* p<0.05, † p<0.01 compare to the control current at a given concentration of capsaicin.
Icap, capsaicin-activated rTRPV1 current.3.2. Potentiation of the capsaicin-activated rTRPV1
current by cytoplasmic 2-APB
The effect of 2-APB on the capsaicin-activated rTRPV1 current
(Icap) was investigated in the inside-out patches. To this end,
we applied 2-APB either from the intracellular side or extracel-
lular side of the inside-out patch membrane, and the changes
in amplitudes of Icap were compared. For this comparison, we
added 1mM2-APB simultaneouslywith 10Mcapsaicin at theend of each recording and the obtained maximum Icap was
used to normalize a given current.
As shown in Fig. 3A, capsaicin (0.1–10M) dose-
dependently activated Icap and 1mM 2-APB added from
cytoplasmic face further increased the current. Cytoplas-
mic application of 2-APB with increasing concentrations of
0.1mM, 0.5mM, and 1mM increased Icap (Fig. 3). As illustrated
in Fig. 3E, the Icap activated by 3M capsaicin was increased
from 3.1±0.7% (n=11) to 5.5±1.7% (n=9), 9.7±4.1% (n=5,
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Fig. 4 – Potentiation of the 2-aminoethoxydiphenyl borate (2-APB)-activated rat transient receptor potential cation channel
subfamily V member 1 (rTRPV1) current by capsaicin. (A) The cytoplasmic 2-APB dose-dependently activated rTRPV1 in the
absence of capsaicin. As in Fig. 3, normalization of the current was performed with 1mM 2-APB and 10M capsaicin. (B–D)
Potentiation of the cytoplasmic 2-APB-activated currents by capsaicin (0.3–1M) are illustrated. (E) Summarized data are
plotted. Detail values are described in text. IAPB: 2-APB-activated rTRPV1 current.
* p<0.05 compare to the control.
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<0.05), and 35.8±10.2% (n=9, p<0.01) by 0.1mM, 0.5mM,
nd 1mM 2-APB, respectively. Icap activated by 10M cap-
aicin was increased from 10.8±2.7% (n=11) to 29.5±6.8%
n=9, p<0.05), 34.8±10.4% (n=5, p<0.01), and 100% (n=9,
< 0.01) by 0.1mM, 0.5mM, and 1mM 2-APB, respectively.3.3. Potentiation of the 2-APB-activated rTRPV1
current by capsaicinTo prove the reciprocal stimulation between capsaicin and
2-APB, we tested whether the pretreatment of capsaicin
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Fig. 5 – Potentiation of the capsaicin-activated rat transient receptor potential cation channel subfamily V member 1
(rTRPV1) current by extracellular 2-aminoethoxydiphenyl borate (2-APB).(A–C) In the inside-out mode, the indicated
concentration of 2-APB was included in the patch pipette ([2-APB]ext), and the amplitudes of capsaicin-activated currents
were compared. For normalization, 1mM 2-APB was applied from the cytoplasmic side ([2-APB]cyt) at the end of each
recording. (D) Summarized data.
* p<0.01.
potentiates the 2-APB-induced opening of rTRPV1 chan-
nels. As illustrated in Fig. 4, pretreatment of an increasing
concentrations of capsaicin (0.3–1M) strongly potentiated
the current activated by intracellular 2-APB. In the absence
of capsaicin, the 1mM 2-APB-evoked current (4.79±1.4%,
n=4) increased to 10.37±4.4% (n=3), 12.8±5.1% (n=3), and
43.4±13.2% (n=6, p<0.05) by 0.3M, 0.5M, and 1M cap-
saicin (Fig. 4E).
3.4. Potentiation of the capsaicin-activated rTRPV1
current by extracellular 2-APB
In Fig. 5, increasing concentrations of 2-APB (0.1–1mM) were
included in the inside-out patch pipette to stimulate the
channels from the outside of the membrane. As previously
indicated, < 1mM of extracellular 2-APB weakly activated the
channels and no signiﬁcant current was monitored until
capsaicin was added into the cytoplasmic solution. In this
condition, extracellular 2-APB dose-dependently potentiated
Icap as does in the cytoplasmic side. The 10M capsaicin-
activated Icap in the presence of 100M 2-APB (10.8±3.8%,
n=9) was not different from the control shown in Fig. 3
(10.8±2.7%). As shown in Fig. 5B–D, 0.5mM and 1mM 2-APBsigniﬁcantly potentiated the Icap to 48.5±4.9% (n=5, p<0.01)
and 67.4±11.8% (n=4, p<0.01), respectively.
Potentiation effect of 2-APB on Icap was further demon-
strated by the whole-cell recordings (Fig. 6). In whole-
cell mode, 2-APB activated the capsaicin-sensitive current
(Fig. 6A), and Icap was strongly potentiated by 2-APB in a dose-
dependent manner (Fig. 6B). These data strongly indicate that
2-APB and capsaicin reciprocally potentiate the opening of
rTRPV1 channels.
3.5. Potentiation of the heat- and H+-activated rTRPV1
current by 2-APB
The effect of 2-APB on the heat-activated rTRPV1 current
was investigated (Fig. 7). In the inside-out conﬁguration, the
perfusion of preheated (at 50 ◦C) bath solution rapidly acti-
vated rTRPV1 currents. Usually, the heat-gated current rapidly
desensitizes and the channels hardly respond to thenext chal-
lenge. For this reason, we compared the response to 2-APB
from different patches. When heat-activated rTRPV1 current
started to desensitize, we challenged 1mM 2-APB-containing
heated solution. As shown in Fig. 7B, 2-APB added in the
middle of desensitization strongly activated the current and
reduced the speed of desensitization.
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Fig. 6 – 2-Aminoethoxydiphenyl borate (2-APB) activation
of the capsaicin-induced rat transient receptor potential
cation channel subfamily V member 1 (rTRPV1) current in
whole-cell mode. (A) In the whole-cell recording,
extracellular 2-APB (0.01–1mM) activated rTRPV1. (B) 2-APB
dose-dependently potentiated the 0.5M
capsaicin-induced current. In contrast to the inside-out
current, the whole-cell current easily desensitized after
treating 2-APB.
Fig. 7 – 2-aminoethoxydiphenyl borate potentiation of the heat-a
subfamily V member 1 current. (A) The heat (50 ◦C)-activated cur
desensitization was prominent. (B) The current was markedly en
into the cytoplasmic side. Each recording was achieved from a di119
In the next step, we examined whether 2-APB-activated
currents are potentiated by extracellular protons. To this end,
we applied weak acid to the inside-out pipette solution by
preparing the solution at pH 6.3, and the effect of acid on the
2-APB-activated current was compared to the control at pH 7.3
(Fig. 7A). As expected, the response of channels to 2-APB was
strongly enhanced by extracellular acid (Fig. 7B). At extracellu-
lar pH 6.3, normalized amplitudes of the 0.1mM, 0.5mM, and
1mM 2-APB-evoked currents were 8–10-fold larger than the
control responses. At pH 7.3 the currents activated by 10M,
100M, 500M, and 1000M 2-APB were 0.7±0.2%, 0.9±0.4%,
1.7±0.5%, and 4.8±1.5%, respectively (n=4). At pH 6.3, they
were increased to 1.8±0.8%, 7.0±3.0%, 35.3±12.1% (p<0.05),
and 52.2±12.5% (p<0.01), respectively (n=6; Fig. 8C). The data
clearly demonstrate that 2-APB stimulates the activation of
rTRPV1 channels by heat and protons, i.e., they reciprocally
sensitized each other.
3.6. Effect of 2-APB analogue DPBA
To deﬁne the pharmacological requirements for the 2-APB
activation, the effect of structural analogue DPBA was exam-
ined on rTRPV1 with inside-out patches. As shown in Fig. 9A,
Icap was enhanced by the cytoplasmic addition of 1mM DPBA.
Inclusion of 1mM DPBA in the pipette solution increased
Icap and the currents were further activated by 1mM DPBA
applied from the cytoplasmic side (Fig. 9B,Cw). Icapat 10M
capsaicin (13.8±4.6%) was signiﬁcantly potentiated by extra-
cellular DPBA (51.6±8.1%, n=7, p<0.05). Similar to the effect
of acid on the 2-APB current (Fig. 8), intrapipette acid
enhanced the DPBA-induced currents (recordings not shown).
The summarized data are shown in Fig. 9D. At pH 6.3,
1mM DPBA-induced currents were signiﬁcantly higher than
control at pH 7.3 (1.16±0.18%, n=5 vs. 35.1±14.0%, n=4;
p<0.05; Fig. 9D). Therefore, these data suggest that DPBA is
an rTRPV1 agonist and shows similar response to that of 2-
APB.
ctivated rat transient receptor potential cation channel
rent was recorded in the inside-out patches. A rapid
hanced by 1mM 2-aminoethoxydiphenyl borate applied
fferent patch.
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Fig. 8 – Extracellular acid (proton) potentiate the 2-aminoethoxydiphenyl borate (2-APB)-induced rat transient receptor
potential cation channel subfamily V member 1 (rTRPV1) current. (A) At extracellular pH of 7.3, a dose-response of 2-APB
activation of the current was recorded. (B) With the inside-out pipette solution of pH 6.3, the intracellularly applied 2-APB
(10M–1mM) produced a signiﬁcant increase in current. (C) Summarized data are illustrated.
* p<0.05, † p<0.01.
IAPB, 2-APB-induced current.
4. Discussion
A synthetic organic compound, 2-APB has been commonly
used as a general inhibitor of SOCE and TRP channels.
Recently, it was shown that 2-APB is not only an inhibitor
of many native and expressed TRPC and TRPM channels but
also an activator of TRPV1, TRPV2, and TRPV3 channels.16,17
It has been postulated that TRP channels have a common
2-APB binding domain but the channel activity is differently
affected by 2-APB. Among TRP channels, 2-APB at 10–100M
inhibits TRPC1, TRPC3, TRPC5, TRPC6, TRPM3, TRPM7, TRPM8,
and TRPP2.12,16,22,23 At high concentrations (> 100M), 2-APB
selectively activatesTRPV1,V2, andV3 channels.16,19 However,
the stimulatory effect of 2-APB on these thermo-TRPV chan-
nels is not generally accepted, because it is suggested that
the compound has no effect on TRPV2 and hardly activates
TRPV1 expressed in HEK cells.19 This discrepancy has been
explained by the different concentrations of 2-APB used or by
the different expression level of the channels.16,19
The present study attempted to demonstrate the effects
of 2-APB on rTRPV1 channels expressed in HEK cells. Instead
of whole-cell patch clamp recording, by which the 2-APB
activation of TRPV1 was ﬁrst reported, our results were
obtained from excised patches, which excludes an interven-
tion by cytosolic components. TRPV1 modulating molecules
that might affect the response to 2-APB included protein
kinase C,20 protein kinase A,24–26 calmodulin kinase II,21
and regulators of phosphatidylinositol 4,5-bisphosphate (PIP2)metabolism.27,28 TRPV1 channels are easily rundown or
desensitize in response to stimuli, and the contribution of pro-
tein kinase C and calmodulin kinase II on the desensitization
has been reported.20 PIP2 is a substrate of phospholipase C and
is known to inhibit TRPV1 through a speciﬁc domain of the
channel. Furthermore, it is known that 2-APB activates phos-
pholipase C in B lymphocytes and releases the stored Ca2+
from endoplasmic reticulum.15
The plasma membrane side of action for 2-APB has been
suggested to be extracellular, because the intracellular appli-
cation of 2-APB failed to activate TRPV1 and TRPV3 current in
Xenopusoocytes and conventionalwhole-cell recordedHEK293
cells, respectively.16,29 To determine the 2-APB-binding sites,
we applied 2-APB from either side of the membrane in the
inside-out or outside-out patch conﬁguration (Fig. 2). We
clearly demonstrated that 2-APB activates rTRPV1 channels
not only from inside but also from the outside of the mem-
brane. In the inside-out and outside-out modes, the perfusion
of 2-APB-contained bath solution activated the channels in
a dose-dependent manner, i.e., it stimulates the channels
from the inside as well as the outside of the membrane. In
whole-cell conﬁguration, 2-APB also activated TRPV1 chan-
nels (Fig. 6). Therefore, it clearly shows that 2-APB-binding
sites are located on both sides of the membrane. To fur-
ther conﬁrm this, we included 2-APB inside of the recording
pipettes of the inside-out or outside-out mode, thereby stim-
ulating the channels from outside or inside of the membrane,
respectively. To our surprise, however, it needed a higher
concentration of intrapipette 2-APB (> 5mM) to activate the
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Fig. 9 – Activation of rat transient receptor potential cation channel subfamily V member 1 (rTRPV1) current by
diphenylborinic anhydride (DPBA), a 2-aminoethoxydiphenyl borate analog. (A) Control response to capsaicin in the
inside-out patches. 1mM DPBA applied into the cytoplasmic solution ([DPBA]cyt) strongly enhanced the current by capsaicin.
(B) 1mM DPBA was included in the recording pipette ([DPBA]ext). Capsaicin-induced currents were greatly enhanced by
1mM of intrapipette DPBA ([DPBA]ext = 1mM). (C) Summarized data on the effect of 1mM DPBA. (D) The effect of extracellular
pH (7.3 vs. 6.3) on the cytoplasmic DPBA-induced current was summarized.
* p<0.05.
I
c
b
t
c
n
r
b
W
t
a
a
a
T
(
c
CAPB, 2-aminoethoxydiphenyl borate-induced current.
hannels sufﬁciently (Fig. 2). This was an unexpected result,
ecause<500M of 2-APB applied from the bath solution of
he inside-out or outside-out patches readily activated a dis-
ernible current, regardless of the expression level of the chan-
els. In the present study, we could not thoroughly explain the
eason for this phenomenon. Chelation or adsorption of 2-APB
y the glass pipette may be suggested but needs to be proved.
hen 2-APB was included in the patch pipette solution for
he excised patches, accumulation of the membrane perme-
ble 2-APB at the extrapipette side (bath solution) is hard to
chieve as the drug will be rapidly diluted by the bath solution
nd will be washed away by perfusion. Therefore, activation of
RPV1 current by the intrapipette 2-APB in the excised patches
inside-out or outside-out modes) further supports that 2-APB
an activate TRPV1 from both sides of the plasma membrane.
onversely, the membrane permeable 2-APB can accumulateat the pipette side even though it is applied to the extrapipette
side of the excised patch membrane.30
Activation of TRPV1, TRPV2, and TRPV3 channels by 2-
APB has been reported by whole-cell recordings and [Ca2+]i
measurement.16 Because 2-APB commonly activated TRPV1,
TRPV2, and TRPV3, it is suggested that these channels share
structural similarity and are gated by similar mechanisms.
Interestingly, the sensitivity of channels to 2-APB, revealed
by the order of half maximal effective concentration values,
follows the order of temperature threshold of each chan-
nel: TRPV3 (> 32 ◦C), TRPV1 (> 43 ◦C), and TRPV2 (> 52 ◦C). To
ﬁnd the 2-APB-binding site, Hu et al16 applied 1mM 2-APB
to the inside of the whole-cell recording pipette and waited
more than 6minutes after breaking the membrane of TRPV3-
expressing HEK cells. However, they failed to record the TRPV3
current in this condition. Furthermore, they failed to activate
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TRPV1 expressed in Xenopus oocytes by the intracellular injec-
tion of 40mM 2-APB. Based on these results, they suggested
that 2-APB-binding sites are located at the extracellular side of
the membrane. This is, however, clearly contradictory to our
present data. We recorded TRPV1 current mainly by inside-
out patches, and the cytoplasmic perfusion of 2-APB activated
the channels with no exception. In the outside-out patches,
cytoplasmic application of 2-APB through the patch pipette
activated the current, although it requires a relatively higher
concentration. More interestingly, even in the presence of a
higher concentration of 2-APB in the recording pipette (i.e.,
5mM 2-APB in the inside-out or outside-out patch pipettes),
a low concentration of 2-APB applied from the opposite side
of the membrane further activated the current (Fig. 2Aii, Bii).
There are two possible explanations for the responses. First,
intracellular and extracellular 2-APB molecules cooperate or
potentiate each other when they simultaneously occupy their
binding sites, thus they produce a supra-additive response.
As 2-APB does on capsaicin, heat, and protons to potentiate
TRPV1, each 2-APB molecule from the opposite side of the
membrane can potentiate each other to open the channels.
Second, a simple additive effect of TRPV1 opening by 2-APB
can be postulated. When 2-APB binds to the channel simul-
taneously from the inside and outside of the membrane, they
independently activate the channels without any interruption
to the opposite. We think that the former seems plausible,
because the current activated by the ﬁrst arrived 2-APB is
always smaller than the current activated by the latter (Fig. 2).
In contrast to our results that show two 2-APB-binding sites
on rTRPV1, it has been suggested that the blocking site of
TRPC3, C5, V1, and V3 channels by 2-APB is located only at the
extracellular face.12,16,23 In expressed human TRPC5 channels,
it was suggested that one 2-APB molecule binds per channel
with mild voltage-dependence and the extracellular blocking
site is exclusive for 2-APB without sharing with other Ca2+
channel blockers.12 We could not completely explain the rea-
son for this discrepancy, and it remains to be elucidated.
It has been shown that 2-APB stimulates the response to
capsaicin, heat, acid, and sensitizes native TRPV1-expressing
nociceptive neurons to heat in a mouse model.16,18 Our
present study strongly supports this suggestion. We clearly
demonstrate evidence supporting the stimulatory roles of 2-
APB on the heterologously expressed TRPV1 by using the
cell-free, excised patch clamp: (1) 2-APB directly activates
rTRPV1 (Fig. 2, 10); (2) 2-APB and capsaicin reciprocally poten-
tiate the stimulatory effect on rTRPV1 (Fig. 3–6); (3) 2-APB
potentiates the response to heat and protons (Fig. 7, 8); and
(4) DPBA potentiates the response to capsaicin and protons
(Fig. 9).
It still remains a mystery how 2-APB activates and sen-
sitizes the capsaicin-activated TRPV1 channel. In Xenopus
oocytes expressing TRPV1, 2-APB left-shifted the dose-
response curves for capsaicin and the pH dependence by
several fold. Conversely, capsaicin left-shifted the dose-
response curve to 2-APB several-folds.16 We showed that
2-APB applied from the cytoplasmic side (Fig. 3) or extracel-
lular side (Fig. 5) sensitized capsaicin-evoked rTRPV1 current
and shifted the dose-response curve to the left, which is in
accordance with previous suggestions.16 TRPV1 can be acti-
vated by a number of lipophilic molecules.31 Increasing theIntegr Med Res ( 2 0 1 3 ) 112–123
content of the plasma membrane cholesterol lowers the tem-
perature sensitivity and shifts the threshold of TRPV1 to
higher temperature range, and themembrane PIP2 hold TRPV1
in an inhibitory state.28,30 2-APB is a lipophilic molecule and
can accumulate in the plasma membrane bilayer at higher
concentrations. Therefore, 2-APB could disrupt the interaction
between TRPV1 and the inhibitory membrane lipids (PIP2 and
cholesterol) and sensitize the channel to various agonists.30
Because the effects of 2-APB on TRPV1 channels require
a higher concentration and are relatively nonspeciﬁc, at
present, it is unlikely to be used for therapeutic and clini-
cal uses. Chemical modiﬁcation of the structure of 2-APB can
generate various analogs with greater differences in the afﬁn-
ity and selectivity to TRPV1 channel and/or TRPV1-interacting
molecules to enhance or reduce the channel activity. If the
chemically modiﬁed 2-APB analogs have highly speciﬁc TRPV1
inhibitory activities at lower concentrations, they can be used
as therapeutic tools to reduce TRPV1-mediated inﬂammatory
pain. In addition, 2-APB analogs can be used for the develop-
ment of a speciﬁc antagonist for SOCE channels, which are
pivotal for many immunological and cardiovascular diseases.
Recent progress on the synthesis of 2-APB analogs with higher
speciﬁcity for SOCE channel should certainly accelerate the
discovery of therapeutic drugs for many TRP channel-related
diseases.32
In conclusion, our data suggest that 2-APB directly opens
rTRPV1 channels and strongly potentiates the effects of well-
known TRPV1 agonists. Binding sites of 2-APB on TRPV1
channels are judged to be located on both sides of the mem-
brane. Because DPBA shows the same effects, it is suggested
that 2-APB and its analogs could be attractive candidates for
the development of a selective TRPV1 agonist and/or antago-
nist.
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